Literature DB >> 9126055

Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats.

D C Anthony1, S J Bolton, S Fearn, V H Perry.   

Abstract

In adult rats, 50,000 units of recombinant interleukin-1 beta (IL-1 beta) injected into the brain parenchyma produced an intense meningitis and disruption of the blood-CSF barrier by 4 h. No increase in vascular permeability to horseradish peroxidase or leukocyte recruitment was observed at the site of injection. By contrast, in juvenile rats, 100 units of IL-1 beta injected into the striatum gave rise to a large increase in blood-brain barrier permeability and recruitment of polymorphonuclear neutrophils into the tissue around the injection site by 4 h. This effect was also accompanied by a marked meningitis. The injection of 100 units of IL-1 beta into neonatal (2-h-old) rats gave rise to an increase in permeability of vessels to serum proteins in the meninges, but no increase in vascular permeability was observed at the injection site. The IL-1 beta-induced increases in vessel permeability in the meninges, parenchyma, and choroid plexus were polymorphonuclear neutrophil dependent, since leukocyte depletion by irradiation or polymorphonuclear neutrophil anti-serum pre-treatment eliminated the response in the juvenile animals and in the adults. Seventy-five thousand units of murine tumour necrosis factor-alpha injected into the parenchyma of both adults and juvenile animals failed to induce an increase in blood-brain barrier permeability or polymorphonuclear neutrophil recruitment, but did give rise to a mild meningitis. These findings demonstrate clear differences in the responsiveness of different CNS compartments to IL-1 beta. Furthermore, while tumour necrosis factor-alpha and IL-1 beta might have been expected to exhibit similar proinflammatory effects in the CNS, this is not the case. We also show, for the first time, that age has a significant effect on the response to a cytokine. The "window of susceptibility' to an inflammatory stimulus in juvenile rats, if paralleled in humans, may be a major factor in the increased susceptibility of children to trauma or to infectious insults to the CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126055     DOI: 10.1093/brain/120.3.435

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  75 in total

Review 1.  Inflammation processes in perinatal brain damage.

Authors:  Vincent Degos; Géraldine Favrais; Angela M Kaindl; Stéphane Peineau; Anne Marie Guerrot; Catherine Verney; Pierre Gressens
Journal:  J Neural Transm (Vienna)       Date:  2010-05-15       Impact factor: 3.575

2.  Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

Authors:  Yuling Zhao; Matthew J Haney; Vivek Mahajan; Benjamin C Reiner; Anna Dunaevsky; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  J Nanomed Nanotechnol       Date:  2011-09-10

3.  Macrophages with cellular backpacks for targeted drug delivery to the brain.

Authors:  Natalia L Klyachko; Roberta Polak; Matthew J Haney; Yuling Zhao; Reginaldo J Gomes Neto; Michael C Hill; Alexander V Kabanov; Robert E Cohen; Michael F Rubner; Elena V Batrakova
Journal:  Biomaterials       Date:  2017-06-18       Impact factor: 12.479

4.  Age-Related Changes in Inflammatory Response after Experimental Envenomation: Impact on the Susceptibility to Androctonus australis hector Venom.

Authors:  Wassila Haddad-Ishak-Boushaki; Fatima Laraba-Djebari
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

5.  Identification and treatment of symptoms associated with inflammation in medically ill patients.

Authors:  Robert Dantzer; Lucile Capuron; Michael R Irwin; Andrew H Miller; Helene Ollat; Victor Hugh Perry; Sarah Rousey; Raz Yirmiya
Journal:  Psychoneuroendocrinology       Date:  2007-12-03       Impact factor: 4.905

6.  Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease.

Authors:  Sander I van Kasteren; Sandra J Campbell; Sébastien Serres; Daniel C Anthony; Nicola R Sibson; Benjamin G Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-23       Impact factor: 11.205

7.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

8.  Neutrophil elastase mediates acute pathogenesis and is a determinant of long-term behavioral recovery after traumatic injury to the immature brain.

Authors:  Bridgette D Semple; Alpa Trivedi; Kayleen Gimlin; Linda J Noble-Haeusslein
Journal:  Neurobiol Dis       Date:  2014-12-09       Impact factor: 5.996

Review 9.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species.

Authors:  Bridgette D Semple; Klas Blomgren; Kayleen Gimlin; Donna M Ferriero; Linda J Noble-Haeusslein
Journal:  Prog Neurobiol       Date:  2013-04-11       Impact factor: 11.685

10.  Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.

Authors:  Mohd Ashif Khan; Kamlesh Garg; Dinesh Bhurani; Nidhi Bharal Agarwal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.